Timothy M Mayleben Esperion Therapeutics, Inc. (ESPR) insider trading activity
Timothy M Mayleben is President & CEO of Esperion Therapeutics, Inc.. Currently has a direct ownership of 122,698 shares of ESPR, which is worth approximately $249,076. The most recent transaction as insider was on Dec 30, 2020, when has been sold 10,700 shares (Common Stock) at a price of $2.1 per share, resulting in proceeds of $22,470. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
123K
0%
3M change
0%
12M change
Total Value Held
$249,076
TIMOTHY M MAYLEBEN Transaction History
Also insider at
TMM
Timothy M Mayleben
President & CEO
Ann Arbor, MI